Finally, MATR3 shows modulatory specificity, as a recent study indicates that (early) reduction or removal of MATR3 in/from the nucleus could decrease ALS pathology and symptoms [22]. The gene discussed is MATR3; the disease is amyotrophic lateral sclerosis.